Each year millions of Americans suffer from tendon injuries, resulting in impaired work performance and reduction in quality of life while costing billions of healthcare dollars in treatment. Injured tendons heal poorly and form scar tissue, which is prone to re-injury because of its inferior mechanical strength. Current treatments are largely ineffective in restoring normal structure and function to injured tendons. The objective of this project is to enhance the quality of tendon healing by using newly discovered tendon stem cells (TSCs), platelet-rich plasma (PRP), and engineered tendon matrix (ETM). The TSCs, PRP, and ETM will be implanted into tendon window defects on a well-established rabbit injury model. Then, biological and histological properties of the injured tendon at short and long term time points, 6 and 26 weeks, respectively, will be assessed. In addition, the functional recovery of injured tendons will be evaluated by mechanical testing of tendon specimens to determine their structural and mechanical properties. This study is highly innovative in that a potent combination of tendon-specific regenerative cells (TSCs), natural healing growth factors (PRP), and tendon specific matrix components (ETM) will be explored for the first time to enhance tendon repair. The findings of this study may lead to application of this combination therapy clinically to effectively repair or possibly regenerate injured tendons, thus benefiting millions of tendon injury patients in the United States alone. Moreover, we will use the proven tendon injury mode in this study as a "stepping-stone" for further studying healing problems of other tendon types, including flexor and rotator cuff tendons.
Using a combination of tendon stem cells (TSCs), platelet-rich plasma (PRP), and engineered tendon matrix (ETM), this project aims to enhance repair of acutely injured tendons. The results of this study may lead to a new effective clinical treatment for injured tendons, thus benefiting millions of tendon injury patients in the United States alone. In addition, this study will serve as a stepping-stone for investigating healing problems of other types of injured tendons, including flexor and rotator cuff tendons.
|Zhang, Jianying; Wang, James H-C (2014) Kartogenin induces cartilage-like tissue formation in tendon-bone junction. Bone Res 2:|
|Zhang, Jianying; Wang, James H-C (2014) PRP treatment effects on degenerative tendinopathy - an in vitro model study. Muscles Ligaments Tendons J 4:10-7|
|Zhang, Jianying; Wang, James H-C (2014) Prostaglandin E2 (PGE2) exerts biphasic effects on human tendon stem cells. PLoS One 9:e87706|
|Maeda, Eijiro; Hagiwara, Yasufumi; Wang, James H-C et al. (2013) A new experimental system for simultaneous application of cyclic tensile strain and fluid shear stress to tenocytes in vitro. Biomed Microdevices 15:1067-75|
|Jamison, Joshua; Lauffenburger, Douglas; Wang, James C-H et al. (2013) PKC? localization at the membrane increases matrix traction force dependent on PLC?1/EGFR signaling. PLoS One 8:e77434|
|Yang, Yunfa; Zhang, Jianying; Qian, Yongxian et al. (2013) Superparamagnetic iron oxide is suitable to label tendon stem cells and track them in vivo with MR imaging. Ann Biomed Eng 41:2109-19|
|Jiang, Dapeng; Wang, James H-C (2013) Tendinopathy and its treatment with platelet-rich plasma (PRP). Histol Histopathol 28:1537-46|
|Zhang, Jianying; Middleton, Kellie K; Fu, Freddie H et al. (2013) HGF mediates the anti-inflammatory effects of PRP on injured tendons. PLoS One 8:e67303|
|Zhang, Jianying; Wang, James H-C (2013) The effects of mechanical loading on tendons--an in vivo and in vitro model study. PLoS One 8:e71740|